New Molecule Could Prevent Cancer Recurrence, Scientists Reveal

**Islamabad (Qudrat):** Despite major advancements in cancer treatment over recent decades, one challenge persists: the recurrence of cancer after successful therapy. Many patients recover from chemotherapy or radiation and return to normal life, only to face a relapse years later, sometimes in a more aggressive form.

Medical experts say a key reason for cancer’s return lies in cancer stem cells. Unlike regular cancer cells, these stem cells can remain dormant in the body for long periods and survive chemotherapy, later reactivating to generate new tumor cells.

Researchers at Virginia Commons University, including Professor Amash Desai and cancer scientist Bhaumik Patel, have developed a novel molecule using Glycosaminoglycans that targets and destroys these hidden stem cells. Laboratory experiments showed the molecule effectively eliminated stem cells in cancers of the intestines, lungs, brain, kidneys, and pancreas without causing harmful or toxic effects.

Scientists believe this approach not only has the potential to prevent cancer recurrence but may also strengthen the immune system. While still in early experimental stages, the method offers a promising path for the future of cancer treatment, potentially reducing relapse rates and revolutionizing global cancer therapy.